Expert Perspective
6m Read
January 13, 2026
RESPIRATORY HEALTH
Article
4m Read
September 09, 2025
RESPIRATORY HEALTH
Main Menu
-
Solutions
Back
Cepheid’s Solutions
-
Global Access
-
Testing Everywhere
Back
Testing Everywhere
-
Antibiotic Stewardship
-
Customized Testing for Your Institution
-
Knowing MORE Matters
-
-
Insights
Back
Cepheid’s Insights
-
Webinars
Back
Webinars
-
Cepheid RADAR
Back
Cepheid RADAR
-
Support
Back
Support Center
-
Documents & Technical Resources
-
Troubleshooting and How-tos
-
MyCepheid and Order Support
-
Contact Us
Back
Contact Us
-
-
About Us
Back
About Cepheid
-
Mission and History
Back
Mission and History
-
Our Leadership
Back
Our Leadership
-
Events
Back
Events
-
Distributors
Back
Distributors
-
Business Development Opportunities
-
Innovate with Cepheid
-
Meet the Cepheid Bike
-
News
Back
News
-
Careers
Back
Careers
-
The Need
- In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections1
- Sensitivities of Rapid EIA Flu tests range from 50-70%2
- Sensitivities of Rapid Antigen RSV tests average 29% in adults3
- Both Rapid EIA and Antigen manufacturers suggest confirming negative results with RT-PCR or culture2
(1) Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3)Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3)Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
The Solution
- Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes* for patients of all ages
- Provides PCR results to support clinical decision‑making related to patient management and infection‑control considerations
- Molecular testing has been shown to support laboratory workflow efficiency in integrated health systems.7
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
The Impact
Single‑test workflow that supports on‑demand, random‑access testing flexibility. Combine performance with the capability to run other Xpert® tests on GenXpert® system may support laboratory workflow efficiency in certain testing environments
Be Proactive
Be Proactive
- Achive fast results to support patient management
- Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
- Quickly deliver targeted therapies
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.